FULC – Fulcrum Therapeutics Inc
Fulcrum Therapeutics, Inc.FULC
$3.96Name : Fulcrum Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $213,597,248.00
EPSttm : -0.29
Fulcrum Therapeutics, Inc.
$3.96
0.50%$0.02Float Short %
9.31
Margin Of Safety %
Put/Call OI Ratio
0.03
EPS Next Q Diff
0.09
EPS Last/This Y
1.44
EPS This/Next Y
-0.9
Price
3.96
Target Price
5.67
Analyst Recom
2.57
Performance Q
9.39
Relative Volume
0.52
Beta
2.05
Ticker: FULC
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | FULC | 4.03 | 0.17 | 0.61 | 19061 |
| 2024-12-20 | FULC | 4.36 | 0.17 | 0.10 | 19115 |
| 2024-12-23 | FULC | 4.68 | 0.03 | 0.04 | 15308 |
| 2024-12-24 | FULC | 4.55 | 0.04 | 0.11 | 15529 |
| 2024-12-26 | FULC | 4.84 | 0.04 | 0.02 | 15767 |
| 2024-12-27 | FULC | 4.8 | 0.04 | 0.00 | 15747 |
| 2024-12-30 | FULC | 4.68 | 0.04 | 0.08 | 15747 |
| 2024-12-31 | FULC | 4.7 | 0.04 | 0.04 | 15755 |
| 2025-01-02 | FULC | 4.85 | 0.04 | 0.00 | 15760 |
| 2025-01-03 | FULC | 5.09 | 0.04 | 0.00 | 15931 |
| 2025-01-06 | FULC | 4.93 | 0.04 | 0.00 | 15940 |
| 2025-01-07 | FULC | 4.88 | 0.04 | 0.00 | 15967 |
| 2025-01-08 | FULC | 4.47 | 0.04 | 0.00 | 16052 |
| 2025-01-09 | FULC | 4.48 | 0.04 | 0.00 | 16052 |
| 2025-01-10 | FULC | 4.37 | 0.04 | 0.00 | 16195 |
| 2025-01-13 | FULC | 4.18 | 0.04 | 0.20 | 16244 |
| 2025-01-14 | FULC | 4.05 | 0.04 | 0.00 | 16248 |
| 2025-01-15 | FULC | 4.1 | 0.04 | 0.00 | 16237 |
| 2025-01-16 | FULC | 3.98 | 0.04 | 0.00 | 16269 |
| 2025-01-17 | FULC | 3.97 | 0.03 | 0.12 | 16246 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | FULC | 4.03 | 27.8 | - | -0.15 |
| 2024-12-20 | FULC | 4.36 | 27.8 | - | -0.15 |
| 2024-12-23 | FULC | 4.68 | 28.2 | - | -0.15 |
| 2024-12-24 | FULC | 4.55 | 28.2 | - | -0.15 |
| 2024-12-26 | FULC | 4.84 | 28.2 | - | -0.15 |
| 2024-12-27 | FULC | 4.80 | 28.2 | - | -0.15 |
| 2024-12-30 | FULC | 4.68 | 28.2 | - | -0.15 |
| 2024-12-31 | FULC | 4.70 | 28.2 | - | -0.15 |
| 2025-01-02 | FULC | 4.85 | 28.2 | - | -0.15 |
| 2025-01-03 | FULC | 5.08 | 28.2 | - | -0.15 |
| 2025-01-06 | FULC | 4.94 | 28.2 | - | -0.15 |
| 2025-01-07 | FULC | 4.89 | 28.2 | - | -0.15 |
| 2025-01-08 | FULC | 4.48 | 28.2 | - | -0.15 |
| 2025-01-09 | FULC | 4.48 | 28.2 | - | -0.15 |
| 2025-01-10 | FULC | 4.37 | 28.2 | - | -0.15 |
| 2025-01-13 | FULC | 4.16 | 28.2 | - | -0.15 |
| 2025-01-14 | FULC | 4.06 | 28.2 | - | -0.15 |
| 2025-01-15 | FULC | 4.09 | 28.2 | - | -0.15 |
| 2025-01-16 | FULC | 3.98 | 28.2 | - | -0.15 |
| 2025-01-17 | FULC | 3.96 | 28.2 | - | -0.15 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | FULC | 0.00 | -17.31 | 10.09 |
| 2024-12-20 | FULC | 0.00 | -17.31 | 10.09 |
| 2024-12-23 | FULC | 0.00 | -17.35 | 10.09 |
| 2024-12-24 | FULC | 0.00 | -17.35 | 10.09 |
| 2024-12-26 | FULC | 0.00 | -17.35 | 9.36 |
| 2024-12-27 | FULC | 0.00 | -17.35 | 9.36 |
| 2024-12-30 | FULC | 0.00 | -17.93 | 9.36 |
| 2024-12-31 | FULC | 0.00 | -17.93 | 9.36 |
| 2025-01-02 | FULC | 0.00 | -17.93 | 9.36 |
| 2025-01-03 | FULC | 0.00 | -17.93 | 9.36 |
| 2025-01-06 | FULC | 0.00 | -17.86 | 9.36 |
| 2025-01-07 | FULC | 0.00 | -17.86 | 9.36 |
| 2025-01-08 | FULC | 0.00 | -17.86 | 9.36 |
| 2025-01-09 | FULC | 0.00 | -17.86 | 9.36 |
| 2025-01-10 | FULC | 0.00 | -17.86 | 9.36 |
| 2025-01-13 | FULC | 0.00 | -9.81 | 9.31 |
| 2025-01-14 | FULC | 0.00 | -9.81 | 9.31 |
| 2025-01-15 | FULC | 0.00 | -9.81 | 9.31 |
| 2025-01-16 | FULC | 0.00 | -9.81 | 9.31 |
| 2025-01-17 | FULC | 0.00 | -9.81 | 9.31 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.35
Avg. EPS Est. Current Quarter
-0.29
Avg. EPS Est. Next Quarter
-0.26
Insider Transactions
Institutional Transactions
-9.81
Beta
2.05
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
30
Growth Score
30
Sentiment Score
18
Actual DrawDown %
88
Max Drawdown 5-Year %
-92.7
Target Price
5.67
P/E
Forward P/E
PEG
P/S
2.64
P/B
0.83
P/Free Cash Flow
EPS
-0.31
Average EPS Est. Cur. Y
-0.15
EPS Next Y. (Est.)
-1.05
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-22.15
Relative Volume
0.52
Return on Equity vs Sector %
-26
Return on Equity vs Industry %
-13.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.09
EBIT Estimation
Fulcrum Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 76
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy is under phase III clinical trial; and pociredir, a fetal hemoglobin inducer for the treatment of sickle cell disease and beta-thalassemia is under phase I clinical trial. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmonary diseases. It has collaboration and license agreement with Acceleron Pharma Inc. to identify biological targets to modulate specific pathways associated with a targeted indication within the pulmonary disease space; MyoKardia, Inc. to discover and develop therapies for the treatment of genetic cardiomyopathies; and Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of facioscapulohumeral muscular dystrophy. Fulcrum Therapeutics, Inc. was Incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
stock quote shares FULC – Fulcrum Therapeutics Inc Stock Price stock today
news today FULC – Fulcrum Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FULC – Fulcrum Therapeutics Inc yahoo finance google finance
stock history FULC – Fulcrum Therapeutics Inc invest stock market
stock prices FULC premarket after hours
ticker FULC fair value insiders trading